The protein DOR controls the maturation of adult flies depending on availability of nutrients
The new programme will promote interdisciplinary research and mobility between scientists.
Scientists at IRB Barcelona develop a computational strategy to identify potential protein interaction partners regulated by Aurora A kinase.
Scientists at IRB Barcelona have provided new data on how certain types of aggressive breast cancer bypass tumour suppression mechanisms.
In collaboration with the Barcelona Science Park (PCB), IRB Barcelona will be participating in Science Week, the largest public communications event on science and technology in Spain, which this year reached its 15th series. Coordinated by the “Fundació Catalana per a la Recerca i la Innovació” (FCRI), the programme of activities will be held from 12 to 22 November.
The activities include open days on 16 and 18 November. Entitled “Come and do an express PhD”, through a series of clues visitors will analyse the differences between malignant and benign tumour cells. In this regard, they will visit Eduard Batlle’s lab, the Advanced Digital Microscopy Platform and the “Centro...
The new data base, which includes 1,700 proteins in motion, allows a more efficient design of drugs.
MoDEL holds 30% of human therapeutic targets and the objective is to cover 80% in three years.
The biotech enterprise Omnia Molecular, which operates from the PCB-Santander Bioincubator at the Barcelona Science Park and was founded by IRB Barcelona researcher Lluís Ribas de Pouplana, has closed funding negotiations headed by “Caixa Capital Risc”, the risk capital section of “la Caixa", worth 2.1M€ . This round of funding, which is supported by the Empresa Nacional de Innovación (ENISA), has also involved the founding partners of Omnia Molecular (Lluís Ribas, Juan Gargallo y Eugeni Roure) and the new managerial team, comprised by Raphael Klingmann, who serves as CEO, and Dariusch Mani.
Omnia Molecular is devoted to the discovery and...
Researchers Dario Alessi and Joan Guinovart bring together 150 experts in cancer Metabolism in a Barcelona BioMed Conference, organised by IRB Barcelona and the BBVA Foundation.
Today, Joan J. Guinovart, director of the Institute for Research in Biomedicine (IRB Barcelona), has been admitted as a new member to the “Reial Acadèmia de Farmàcia de Catalunya” (Catalan Royal Academy of Pharmacy).
This finding has brought them the “Paper of the week” of the Journal of Biological Chemistry, one of the journals of greatest impact in basic biology.
Called SLIMP, the protein is required for mitochondria maintenance, the cellular powerhouses.